138 related articles for article (PubMed ID: 21440768)
21. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
22. High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease.
Satirapoj B; Supasyndh O; Nata N; Phulsuksombuti D; Utennam D; Kanjanakul I; Choovichian P; Duangurai K
J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S65-70. PubMed ID: 21280518
[TBL] [Abstract][Full Text] [Related]
23. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
[TBL] [Abstract][Full Text] [Related]
24. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
25. Hyperhomocysteinemia after kidney transplantation.
Einollahi B; Lessan-Pezeshki M; Kalantar E; Rostami Z; Khalili N; Ghadiani MH; Ahmadi J
Transplant Proc; 2011 Mar; 43(2):586-7. PubMed ID: 21440769
[TBL] [Abstract][Full Text] [Related]
26. [Clinical studies on hyperuricemia and gout after transplantation].
Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
[TBL] [Abstract][Full Text] [Related]
27. Hyperuricemia after liver transplantation in children.
Harambat J; Dubourg L; Ranchin B; Hadj-Aïssa A; Fargue S; Rivet C; Boillot O; Lachaux A; Cochat P
Pediatr Transplant; 2008 Dec; 12(8):847-53. PubMed ID: 18537903
[TBL] [Abstract][Full Text] [Related]
28. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
[TBL] [Abstract][Full Text] [Related]
29. Complications of Renal Transplantation That Influence the Presence of Hyperuricemia in Its First Year of Evolution.
Cheng MDCA; Pérez RE; Santiago JC; Galindo AC; Carreño Rodríguez YR; Guerrero Rosario AO; Meléndez AR; Villanueva AI; Jiménez EM; Bobadilla Lugo RA; De León CV; Hernández Rivera JCH; Sierra RP
Transplant Proc; 2020 May; 52(4):1147-1151. PubMed ID: 32197869
[TBL] [Abstract][Full Text] [Related]
30. [Purine metabolism in patients with renal failure].
Hosoya T; Ohno I; Uetake D; Saikawa H
Nihon Rinsho; 2004 Jun; 62 Suppl 6():136-41. PubMed ID: 15250282
[No Abstract] [Full Text] [Related]
31. Renal transplantation after failure of a first graft.
Waltzer WC; Zincke H; Sterioff S; Offord KP; Frohnert PP
Surg Gynecol Obstet; 1981 Apr; 152(4):476-82. PubMed ID: 7010644
[TBL] [Abstract][Full Text] [Related]
32. Delayed kidney allograft function after simultaneous pancreas-kidney transplantation.
Rangel EB; Melaragno CS; Gonzalez AM; Linhares MM; de Sá JR; Salzedas A; Medina-Pestana JO
Transplant Proc; 2010 Nov; 42(9):3655-9. PubMed ID: 21094834
[TBL] [Abstract][Full Text] [Related]
33. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for immediate anemia in renal transplant recipients: a single-center experience.
Rostami Z; Shafighi N; Baghersad MM; Einollahi B
Transplant Proc; 2011 Mar; 43(2):581-3. PubMed ID: 21440767
[TBL] [Abstract][Full Text] [Related]
35. Long term survival and graft function after cadaver kidney transplantation.
Lund F; Thaysen JH; Ladefoged J; Nerstrom B
Acta Chir Scand Suppl; 1976; 472():9-12. PubMed ID: 801100
[TBL] [Abstract][Full Text] [Related]
36. Preemptive living-donor renal transplantation: outcome and clinical advantages.
Yoo SW; Kwon OJ; Kang CM
Transplant Proc; 2009; 41(1):117-20. PubMed ID: 19249492
[TBL] [Abstract][Full Text] [Related]
37. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
[TBL] [Abstract][Full Text] [Related]
38. Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation.
Baker AC; de Mattos A; Watkins S; German JB; Troppmann C; Perez R
J Surg Res; 2010 Dec; 164(2):182-7. PubMed ID: 20855086
[TBL] [Abstract][Full Text] [Related]
39. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
